He aha nā huahana nui a mākou e paipai nei?

ʻO ka hana nui o ka ʻili, ʻo ia ka hana ʻana i mea pale pono ma waena o ke kino kanaka a me kona kaiapuni. Hōʻike ka hana pale ʻino i kahi kūlana mua no ka hoʻomohala ʻana i nā maʻi ʻili e like me ka atopic dermatitis (AD), ʻo ia ka maʻi ʻili maʻamau i hōʻike ʻia e ka maʻi pale ʻili.

I nā poʻe maʻi me ka puʻuwai puʻuwai maʻamau (CHF), ʻōlelo ʻia ka hoʻohana ʻana i ka angiotensinconverting enzyme inhibitors, me ka ramipril, e hōʻemi i ka hopena o ka ulu ʻana o ka puʻuwai puʻuwai, hoʻokipa a me ka make. ʻO kā mākou pahuhopu ka noiʻi ʻana i ka hopena o ka hoʻohui ʻana o ke kino i ka pharmacokinetics o ka ramipril a me kāna metabolite ramiprilat ikaika a me ka loiloi i nā loli i ka pharmacokinetics ma hope o ka lōʻihi o ka mālama ʻana.

ʻO Remifentanil kahi analgesic lāʻau opioid-class ultra-short-acting i hoʻohana nui ʻia "off-label" ma ke ʻano he hoʻoponopono ʻeha i ka wā o ka hana. ʻO nā hopena ʻaoʻao i ka wā hānau keiki, a me ka pēpē i ka hānau ʻana he mea hopohopo nui.